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Mammalian inner ear harbors diverse cell types that are essential for hearing and balance. Adenovirus is one of the major vectors to
deliver genes into the inner ear for functional studies and hair cell regeneration. To identify adenovirus vectors that target specific
cell subtypes in the inner ear, we studied three adenovirus vectors, carrying a reporter gene encoding green fluorescent protein
(GFP) from two vendors or with a genome editing gene Cre recombinase (Cre), by injection into postnatal days 0 (P0) and 4 (P4)
mouse cochlea through scala media by cochleostomy in vivo. We found three adenovirus vectors transduced mouse inner ear
cells with different specificities and expression levels, depending on the type of adenoviral vectors and the age of mice. The most
frequently targeted region was the cochlear sensory epithelium, including auditory hair cells and supporting cells. Adenovirus
with GFP transduced utricular supporting cells as well. This study shows that adenovirus vectors are capable of efficiently and
specifically transducing different cell types in the mammalian inner ear and provides useful tools to study inner ear gene function
and to evaluate gene therapy to treat hearing loss and vestibular dysfunction.
1. Introduction
Irreversible hair cell loss is a major cause of permanent
sensorineural hearing loss with no effective treatment. Patho-
genic variants in hundreds of genes are responsible for
many forms of hereditary hearing loss. The development of
strategies for hair cell regeneration and for gene delivery has
become a major focus in the search for potential therapeutic
approaches to restoring hearing [1–3].
Lower vertebrates including birds and fish can regenerate
hair cells throughout life after hair cell loss by two mecha-
nisms. First, inner ear supporting cells and remaining hair
cells may reenter the cell cycle and differentiate into new
hair cells. Second, surrounding cells located under the lost
hair cells may also directly transdifferentiate into new hair
cells [4–6]. However, the mammalian inner ear has lost the
capacity to regenerate hair cells spontaneously. One strategy
to regenerate hair cells in mammals to restore hearing is
to induce surrounding cells especially supporting cells to
transdifferentiate into hair cells directly. Another approach is
to induce remaining hair cells or supporting cells to reenter
the cell cycle and for supporting cells to further differentiate
to hair cells [1, 7]. Either approach requires efficient delivery
of genes necessary for the induction of these processes into
mammalian inner ear cells.
The inner ear is a particularly attractive organ for targeted
gene therapy, because vectors can be locally delivered to the
enclosed structure, which significantly reduces systemic side
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effects. One of the major hurdles to achieve hair cell regen-
eration or gene correction by gene therapy is the lack of
efficient and specific vehicle to deliver genes intomammalian
inner ear cells. Adenovirus (Ad) and Adeno-associated virus
(AAV) are the most common vectors used for inner ear
gene delivery. Both have been used to successfully transfer
functional genes into the mammalian inner ear for gene
therapy [8–23]. Ad vector is a good choice due to its high
transfection efficiency in diverse tissues and cell types, with
high level of expression soon after infection. Furthermore,
Ad vector has low immunogenicity and toxicity [15–23].
Comparing to AAV vectors, Ad vectors have the capacity
to accommodate larger inserts. For example, the most com-
monly used adenovirus vectors, which are E1/E3 deletion
mutants, allow the insertion of up to 10 kb of foreign DNA
into the viral vector genome, while an AAV can only carry up
to 4.7 kb of foreign DNA [13, 24].
Previous studies have demonstrated the ability of Ad
vectors to transduce cochlear hair cells and supporting cells
[5–13]. In mammalian inner ear, transduction by Ad vectors
is organ (cochlea versus vestibule), cell type (inner hair cells
(IHCs), outer hair cells (OHCs), and supporting cells (SCs)),
region (base, middle, and apical turns), and age dependence.
The transduction patterns of Ad vectors in the inner ear vary.
In order to use Ad vectors to effectively deliver genes into
specific inner ear cell subtypes, it is important to characterize
the transduction patterns of viral vector subtypes under
various experimental conditions, including animal age, route
of inoculation, viral preparations, volume, and number of
viral particles.
To identify commercially available Ad vectors for their
inner ear delivery patterns, we analyzed Ad vectors carrying a
GFP from Baylor College of Medicine (Ad-GFP-Baylor) and
fromVector Biolabs (Ad-GFP-VB) and an Ad vector carrying
GFP linked with a genome editing gene Cre recombinase
(Cre) fromBaylor College ofMedicine (Ad-Cre-GFP-Baylor)
in vivo for their potential for inner ear gene delivery in P0 and
P4 mouse cochleae.
2. Material and Methods
2.1. AdVectors. Weobtained three commercially available Ad
vectors: Ad-GFP-Baylor (Baylor College of Medicine, Hous-
ton, TX, USA), Ad-GFP-VB (Vector Biolabs, Malvern, PA,
USA), and Ad-Cre-GFP-Baylor (Baylor College of Medicine,
Houston, TX, USA). The titers of Ad-GFP-Baylor, Ad-GFP-
VB, and Ad-Cre-GFP-Baylor were 2.5×1010–5×1011 plaque-
forming unit (pfu)/ml, 1×1010 pfu/ml, and 1.7×1011 pfu/ml,
respectively. We consider the titer of Ad-GFP-Baylor as 10 ×
1010 pfu/ml for dilution.We diluted all Ads to 1×1010 pfu/ml
with storage buffer according to the vectors instructions from
two vendors for microinjection.
2.2. Microinjection of Ad Vectors into Mouse Inner Ear.
P0 and P4 CD1 mice (Charles River Laboratory, Wilm-
ington, MA, USA) were used for Ad-Cre-GFP-Baylor, Ad-
GFP-Baylor, and Ad-GFP-VB injection, according to pro-
tocols approved by the Massachusetts Eye & Ear Infirmary
IACUC committee. Mice were anesthetized by lowering their
temperature on ice. Cochleostomies were performed by
making an incision behind the right ear to expose the cochlea.
Glass micropipettes (WPI, Sarasota, FL, USA) held by a
Nanoliter Microinjection System (WPI, Sarasota, FL, USA)
were used to deliver the Ad into the scala media, which
allows access to inner ear cells. A total volume of ∼0.2 𝜇L
was injected per cochlea on the right side and the release was
controlled by a micromanipulator at the speed of 3 nL/sec.
The left cochlea was left intact as an internal control.
2.3. Immunofluorescence and Quantification. Four days after
injection, mice were sacrificed and cochleae were harvested
by standard protocols [1, 17]. For whole-mount immunoflu-
orescence, primary antibodies against HC (MYO7A, #25-
6790, Proteus Biosciences) and SC (SOX2, #sc-17320, Santa
Cruz Biotech) markers and fluorescent-labeled secondary
antibodies (Invitrogen) were used following a previously
described protocol [1]. To quantify the proportion of GFP
positive cells after Ad injection, we counted the number of
GFP positive IHCs, OHCs, and SCs, which were then divided
by the total number of IHCs, OHCs, and SCs, respectively, in
a region spanning 200𝜇m in the apical, middle, or basal turn
of the cochlea.
3. Results
We injected Ad vectors into the neonatal mouse inner ear
at P0 or P4 via cochleostomy, because previous studies have
shown that injection of AAV into the neonatal mouse cochlea
by cochleostomy resulted in efficient transduction in vivo
without adversely affecting hearing [8]. Four days after injec-
tion of any of the three Ad vectors into P0 or P4 mouse inner
ears, cochlear structures remained intact and hair cells and
supporting cells survived, indicating that the injection andAd
transduction did not damage inner ear cells (Figures 1–7).
We assessed the transduction efficiency of the viral
vectors by calculating the proportion of GFP positive cells,
because all three Ad vectors carried the GFP gene. Whole-
mount immunofluorescence labeling of HC and SC markers
Myo7a and Sox2 identified hair cells and supporting cells,
respectively. We found that the Ad-Cre-GFP-Baylor trans-
ductionwas restricted to the injected side and noGFP expres-
sion was observed in the uninjected inner ear (Figure 1(d)).
Same was true for Ad-GFP-Baylor and Ad-GFP-VB (data not
shown). Our results confirmed that targeted delivery of Ad
vectors via cochleostomy was confined within the injected
inner ear.
Our results showed that three different Ad vectors
injected at two different ages transduced different cell types in
different cochlear regions with varying efficiencies (Table 1).
Ad-Cre-GFP-Baylor, when injected at P0, efficiently trans-
duced more than 70% of SCs but not HCs in the basal and
middle turns (Figures 1(a) and 1(b)). It transduced few cells
in the apical turn (Figure 1(c)). Comparing to injection at P0,
injected at P4, Ad-Cre-GFP-Baylor transduced fewer SCs in
the basal and middle turns, but more SCs in the apical turn
(Figure 4).
A similar trend of transduction efficiency in SCs was
observed for Ad-GFP-Baylor (Table 1). It transduced inner
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Figure 1: Ad-Cre-GFP-Baylor transduces supporting cells when injected intomouse cochlear at P0. Representative confocal images of whole-
mount fluorescent immunolabeling of cochlea injected at P0 to illustrate the basal (a), middle (b), and apical turns (c), as compared to the
contralateral uninjected middle turn of cochlea (d). Myo7a labels hair cells, and Sox2 labels supporting cells. Ad-Cre-GFP-Baylor mainly
transduces supporting cells in basal and middle turns. Scale bars: 10 𝜇m.
Table 1: Comparison of in vivo transduction efficiency in different cell types and cochlear regions four days after injection of three adenoviral
vectors into P0 or P4 mouse cochleae. 𝑁 = 4 per condition. Apical: apical turn of the cochlea, basal: basal turn of the cochlea, IHCs: inner
hair cells, middle: middle turn of the cochlea, OHCs: outer hair cells, P0: injected at postnatal day 0, P4: injected at postnatal day 4, and SCs:
supporting cells.
Transduction efficiency (%) IHCs OHCs SCs
Basal Middle Apical Basal Middle Apical Basal Middle Apical
Ad-Cre-GFP-Baylor P0 74.5 ± 8.6 70.6 ± 7.8
P4 54.4 ± 6.8 52.4 ± 6.9 3.8 ± 1.2
Ad-GFP-Baylor P0 9.1 ± 1.2 80.0 ± 12.0 90.8 ± 9.2 84.7 ± 10.6
P4 13.6 ± 2.9 17.4 ± 4.2 79.1 ± 10.6 74.3 ± 11.2 42.3 ± 6.1
Ad-GFP-VB P0 9.1 ± 1.5 15.0 ± 4.8 9.8 ± 1.8 29.0 ± 4.9 27.8 ± 4.1 41.5 ± 8.1 7.7 ± 2.9
P4 2.9 ± 0.9 51.1 ± 6.2 33.1 ± 4.2
ear cells more efficiently than Ad-Cre-GFP-Baylor when
injected at either P0 (Figure 2) or P4 (Figure 5). Furthermore,
it also transduced a majority of OHCs in the apical turn and
some IHCs in the basal turn when injected at P0 and IHCs in
the middle turn and OHCs in the apical turn when injected
at P4.
In contrast, Ad-GFP-VB transduced fewer SCs than either
of the Ad-GFP-Baylor vectors with an opposite temporal
trend:more efficiently when injected at P4 than at P0 (Table 1,
Figures 3 and 6). Further, it more consistently transduced
IHCs in the middle and apical turns and OHCs along the
whole cochlear coil when injected at P0 (Table 1).
Ad-GFP-Baylor and Ad-GFP-VB transduced vestibular
HCs and SCs with similar patterns when injected at either P0
or P4 (Figure 7), whereas Ad-Cre-GFP-Baylor transduced no
utricular HCs or SCs.
In summary, we compared the transduction patterns of
three Ad vectors injected at two different ages. All three
Ad vectors consistently transduced SCs, with Ad-GFP-Baylor
exhibiting the highest transduction rate across the whole
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Figure 2: Ad-GFP-Baylor transduces diverse cochlear cell types when injected at P0. Representative confocal images of whole-mount
fluorescent immunolabeling of cochlea injected at P0 to illustrate the basal (a), middle (b), and apical turns (c). Ad-GFP-Baylor transduces
supporting cells (SCs) and inner hair cells (IHCs) at basal (a), SCs at middle (b), and outer hair cells (OHCs) at apical turns (c). IHC: inner
hair cell, OHC: outer hair cell, and SC: supporting cell. Scale bars: 10𝜇m.
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Figure 3: Ad-GFP-VB transduces diverse cell types in mouse cochlea when injected at P0. Representative confocal images of whole-mount
fluorescent immunolabeling of the cochlea injected with adenovirus at P0 to illustrate the basal (a), middle (b), and apical turns (c). Ad-GFP-
VB transduces SCs and OHCs at basal (a), OHCs, IHCs, and SCs at middle (b), and OHCs and IHCs at apical turns (c). IHC: inner hair cell,
OHC: outer hair cell, and SC: supporting cell. Scale bars: 10𝜇m.
Neural Plasticity 5
Myo7a GFP Merged/DAPISox2
(a)
Myo7a GFP Merged/DAPISox2
(b)
Myo7a GFP Merged/DAPISox2
(c)
Figure 4: Ad-Cre-GFP-Baylor transduces supporting cells in the mouse cochlear when injected at P4. Representative confocal images of
whole-mount fluorescent immunolabeling mouse cochlea to illustrate the basal (a), middle (b), and apical turns (c). Ad-Cre-GFP-Baylor
transduces SCs at basal and middle turns efficiently. It transduces some SCs at the apical turn. Scale bars: 10 𝜇m.
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(a)
Myo7a GFP Merged/DAPISox2
IHC IHC
(b)
Myo7a GFP Merged/DAPISox2
(c)
Myo7a GFP Merged/DAPISox2
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Figure 5: Ad-GFP-Baylor transduces mouse cochlea when injected at P4. Representative confocal images of whole-mount fluorescent
immunolabeling P0 cochlea to illustrate the basal (a), middle (b), and apical turns (c, d). Ad-GFP-Baylor transduces SCs at basal (a), SCs
and IHCs at middle (b), and SCs and OHCs at apical turns (c). Outer hair cells are transduced at the apical turn (d). IHC: inner hair cell;
OHC: outer hair cell.
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Figure 6: Ad-GFP-VB transduces supporting cells and OHCs in the mouse cochlear when injected at P4. Representative confocal images of
whole-mount fluorescent immunolabeling of the cochlea to illustrate the basal (a), middle (b), and apical turns (c). Ad-GFP-VB transduces
SCs at basal (a) and middle (b) and occasional OHCs at apical turns (arrows in (c)). Scale bars: 10 𝜇m.
Myo7a GFP Merged/DAPISox2
(a)
Myo7a GFP Merged/DAPISox2
(b)
Figure 7: Ad-GFP-Baylor (a) and Ad-GFP-VB (b) transduce supporting cells and hair cells in the mouse utricle when injected at P0.
Representative confocal images of whole-mount fluorescent immunolabeling of the utricle. Scale bars: 10𝜇m.
cochlea. Ad-Cre-GFP-Baylor transduced only SCs in the
basal and middle turns. Ad-GFP-Baylor and Ad-GFP-VB
also transduced some HCs including both IHCs and OHCs
(Table 1). The overall transduction efficiency was lower for
Ad-GFP-Baylor vectors when injected at P4 than at P0 but
higher for Ad-GFP-VB in SCs. Furthermore, Ad-GFP-VB
had a broader transduction pattern when injected at P0 as
it transduced OHCs along the whole cochlea and IHCs at
middle and apex turns, but it only transduced a few OHCs
at the apical turn when injected at P4.
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4. Discussion
This study identified commercial adenovirus viral vectors
that target mouse inner ear cell subtypes for gene delivery.
Three adenovirus vectors transduced P0 and P4 inner ear,
with different specificities and expression levels that are
dependent on the type of adenoviral vectors and the age of
mice. The cochlear sensory epithelium, which harbors audi-
tory hair cells and supporting cells, is transduced with
higher efficiency.The adenovirus with GFP alone transduced
utricular supporting cells. The infected cells survived at the
time of the study (four days after injection). The study shows
that Ad vectors are capable of transducing mammalian inner
ear efficiently and provides useful tools to evaluate gene
therapy and to study inner ear gene function.
There are two approaches of hair cell regeneration: (1)
direct transdifferentiation of surrounding cells especially
supporting cells to change cell fate to become hair cells and
(2) induction of cell cycle re-entry in cells such as supporting
cells, which then further differentiate to replace damaged hair
cells [1, 25, 26]. Thus, supporting cells are ideal candidates
for hair cell regeneration by direct transdifferentiation or by
renewed proliferation with subsequent transdifferentiation.
Moreover, remaining hair cells can divide to generate new
hair cells. Many cases of sensorineural hearing loss and vesti-
bular dysfunction are caused by a primary pathology in
the sensory epithelium [17, 18]. It is therefore important to
express transgenes in the sensory epithelial cells such as
supporting cells specifically.ThreeAd vectors transduced SCs
efficiently, an indication that they could be useful for poten-
tial hair cell regeneration studies. Ad-Cre-GFP-Baylor trans-
duced SCs only at middle and base turns when injected at P0.
The lack of transduction of the apical SCs was likely due to
limited diffusion of the viral particles. Ad-Cre-GFP-Baylor
transduces only SCs, whereas Ad-GFP-Baylor transduced
80%OHCs at apex turn and some IHCs at base turn at P0.Ad-
GFP-VB transduces SCs and OHCs. Each Ad vector can ther-
efore be selected to deliver genes to only SCs, HCs, or both.
The volume and titer of vector inoculation influence
the cell types and location of cells transduced by the virus.
To compare the difference of three virus infection, we use
the same titer of three Ads. It is interesting that Ad-GFP-
Baylor and Ad-Cre-GFP-Baylor had different transduction
specificities. However, according to the instruction of Ad-
GFP-Baylor from Baylor College of Medicine, the virus
particle (vp) to plaque-forming unit (pfu) ratio is in a range
of 1 : 10 to 1 : 200 and the titer is 2.5 × 1010–5 × 1011 pfu/ml.
We used the titer of 10 × 1010 pfu/ml for dilution, which may
be an underestimate of the actual titer as it had the highest
transduction efficiency.
Injection into mouse cochlea through scala media by
cochleostomy maximizes the efficiency as it allows virus to
have access to many cochlear cell types. Previous studies
suggested that, a better outcome of cell survival,mice younger
than P5 should be used, as OHCs will generally die due
to surgery in mice older than P5, especially at adult stage
[8, 9, 13]. Future study needs to focus on identification of a
route by which injection can be performed in adult without
causing cell death or hearing loss.
Combining a therapeutic transgene with a reporter gene
would be informative for easy identification of the cell types
targeted. The human inner ear is much larger in size and
would facilitate a more accurate delivery, which could help
with the development of gene therapy in patients.
5. Conclusions
The present study explored commercial three Ad vectors into
the mouse inner ear in vivo. The results show the feasibility
of gene transfer into mouse inner ear via Ad vectors with
different specificity and efficiency. Future application of gene
delivery for the inner ear may include the induction of
hair cell regeneration and treatment of hereditary deafness
and vestibular dysfunction. The ability of the cochleostomy
to deliver reporter transgenes into a variety of cell types
in the inner ear, including the sensory epithelium, makes
this method attractive to target inner ear cell subtypes.
Continuous improvement in identification of highly efficient
vectors targeting inner ear cell subtypes would advance their
eventual use to treat hearing loss in human.
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